Fuqiang Zhao1, Denise Welsh1, Mangay Williams1, Hongyu Annie Liang2, Alexandre Coimbra1, Mark O. Urban2, Mark Bowlby2, Richard Hargreaves2, Jeffrey L. Evelhoch1, Donald S. Williams1
1Imaging, Merck, West Point, PA, United States; 2Neuroscience, Merck, West Point, PA, United States
Pregabalin (Lyrica) is used for the treatments of epilepsy and pain. Both its anatomical targets and its mechanism of action are poorly understood. In this study, the suppression effects of pregabalin on noxious electrical stimulation (NES) induced responses were investigated by BV fMRI in anesthetized rats, and by behavioral assay (vocalization) in awake rats. Our fMRI and behavioral results suggest that 1) pregabalin has efficacy on NES-induced pain in nave rats; and 2) the analgesic action sites of pregabalin are not in the primary somatosensory pathway (spinal cord, dorsal column nuclei, thalamic relay, S1), but in other activated regions.